KOSDAQ · Healthcare · ₩16T
₩222,500+1.83%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 9.9% · as of 26.10.26
Among 37 신약 개발 peers
Quarterly Revenue Growth
“이번 분기 계약 성과가 실적을 든든하게 끌어올렸어요.”
In the company's words · 2026 2분기 filing